James R Brosnahan

Title: James R Brosnahan: Innovator in Cardiac Monitoring Technology

Introduction

James R Brosnahan is a notable inventor based in River Edge, NJ (US). He has made significant contributions to the field of cardiac monitoring technology. His innovative work has led to the development of a unique patent that enhances the accuracy of heart rate monitoring.

Latest Patents

James R Brosnahan holds a patent for an "Automatic pulse rate trigger-source select circuit." This invention discloses a circuit designed to automatically select between an ECG heartbeat signal source and a pressure/pulse signal source. The selection process depends on which of the two sources is the most periodic between three successive heartbeats. The circuit utilizes a pair of microprocessor internal timers that commence a count-up cycle in response to the first detected heartbeat from each source. Subsequently, count-down cycles are initiated based on the next successive detected heartbeats. The counting of the timers is halted after the third successive detected heartbeats, allowing for a comparison to determine which source is most periodic and should be used to trigger a heart rate monitor.

Career Highlights

James R Brosnahan is currently employed at Datascope Corporation, where he continues to innovate in the field of medical technology. His work at Datascope Corporation has allowed him to apply his expertise in developing advanced cardiac monitoring solutions.

Collaborations

Throughout his career, James has collaborated with notable colleagues, including Jeffrey M Arnold and Terrence H Koong. These collaborations have contributed to the advancement of technology in the medical field.

Conclusion

James R Brosnahan is a distinguished inventor whose work in cardiac monitoring technology has made a significant impact. His patent for the automatic pulse rate trigger-source select circuit exemplifies his commitment to improving medical technology. His contributions continue to influence the field and enhance patient care.